APO Research
Talk to an analyst

APO RESEARCH · REPORT

Needle-Free Injection Device

Needle-free Injection Device is a type of medical injecting syringe that uses a high-pressure narrow jet of the injection liquid instead of a hypodermic needle to penetrate the epidermis. It is powered by compressed air or gas, either by a pressure hose from a large cylinder, or form a built-in gas cartridge, small cylinder, or spring.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Needle-free Injection Device is a type of medical injecting syringe that uses a high-pressure narrow jet of the injection liquid instead of a hypodermic needle to penetrate the epidermis. It is powered by compressed air or gas, either by a pressure hose from a large cylinder, or form a built-in gas cartridge, small cylinder, or spring.

Needle-free injection systems are novel ways to introduce various medicines into patients without piercing the skin with a conventional needle. It was developed to reduce the number of needle stick accidents and associated problems.

Selected research

Market Structure

Global Needle-Free Injection Device Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025191 pages

Choose your research edition.

Industry ResearchNeedle-Free Injection Device Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Needle-Free Injection Device Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Needle-Free Injection Device Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Needle-Free Injection Device Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Needle-Free Injection Device Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

Needle-free Injection Device is a type of medical injecting syringe that uses a high-pressure narrow jet of the injection liquid instead of a hypodermic needle to penetrate the epidermis. It is powered by compressed air or gas, either by a pressure hose from a large cylinder, or form a built-in gas cartridge, small cylinder, or spring.

Needle-free injection systems are novel ways to introduce various medicines into patients without piercing the skin with a conventional needle. It was developed to reduce the number of needle stick accidents and associated problems.

Firstly, the technology of needle-free injection device industry is developing and the industry concentration is not high, There are over 30 manufacturers around the world, and the leading companies are Zogenix, Bioject, Glide Pharma, Crossject Medical and Injex Pharma, right now the production is almost dominated by producers in Europe and United States. In United States, a few companies occupy more than 60 percent of domestic needle-free injector market. On the other hand, almost all the high-end products produced by the global leaders, and the producers mainly produce low-end products in China and India. USA and Europe have a long history and unshakable status in this industry, such as Bioject and Akra Dermojet, leading the needle-free injection device industry. As to Japan, many big corporation has come into this area, however, the rate of the business in this area is not high compared to other area because Japanese companies always have many business areas. In Germany, it is Injex Pharma that lead the industry.

Read the full market overview

This report provides an overview of the global Needle-Free Injection Device market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Needle-Free Injection Device and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Needle-Free Injection Device sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Needle-Free Injection Device market size, projected growth trends, production technologies, key applications, and end-use industries.

Needle-Free Injection Device Segment by Company

Zogenix

Inovio

Glide Pharma

Akra Dermojet

Crossject Medical Technology

Injex Pharma

Eternity Healthcare

Antares Pharma

Valeritas

Medical International Technologies

Penjet

PharmaJet

National Medical Products

Activa Brand Products

Needle-Free Injection Device Segment by Type

Powder Injections

Liquid Injections

Depot or Projectile Injection

Needle-Free Injection Device Segment by Application

Drug Injection

Cosmetic Surgery Use

Other

Needle-Free Injection Device Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Needle-Free Injection Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Needle-Free Injection Device and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Needle-Free Injection Device.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Needle-Free Injection Device market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Needle-Free Injection Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Needle-Free Injection Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Needle-Free Injection Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Needle-Free Injection Device Industry Trends Table 2. Needle-Free Injection Device Industry Drivers Table 3. Needle-Free Injection Device Industry Opportunities and Challenges Table 4. Needle-Free Injection Device Industry Restraints Table 5. Global Needle-Free Injection Device Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Needle-Free Injection Device Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Needle-Free Injection Device Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Needle-Free Injection Device Sales Market Share by Manufacturers Table 9. Global Needle-Free Injection Device Average Sales Price (USD/unit) of Manufacturers (2021-2026) Table 10. Global Needle-Free Injection Device Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Needle-Free Injection Device Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Needle-Free Injection Device Manufacturers, Product Type & Application Table 13. Global Needle-Free Injection Device Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Needle-Free Injection Device by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Powder Injections Table 17. Major Manufacturers of Liquid Injections Table 18. Major Manufacturers of Depot or Projectile Injection Table 19. Global Needle-Free Injection Device Sales by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Needle-Free Injection Device Sales by Type (2021-2026) & (k units) Table 21. Global Needle-Free Injection Device Sales by Type (2027-2032) & (k units) Table 22. Global Needle-Free Injection Device Sales Market Share by Type (2021-2026) Table 23. Global Needle-Free Injection Device Sales Market Share by Type (2027-2032) Table 24. Global Needle-Free Injection Device Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 25. Global Needle-Free Injection Device Revenue by Type (2021-2026) & (k units) Table 26. Global Needle-Free Injection Device Revenue by Type (2027-2032) & (k units) Table 27. Global Needle-Free Injection Device Revenue Market Share by Type (2021-2026) Table 28. Global Needle-Free Injection Device Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Drug Injection Table 30. Major Manufacturers of Cosmetic Surgery Use Table 31. Major Manufacturers of Other Table 32. Global Needle-Free Injection Device Sales by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Needle-Free Injection Device Sales by Application (2021-2026) & (k units) Table 34. Global Needle-Free Injection Device Sales by Application (2027-2032) & (k units) Table 35. Global Needle-Free Injection Device Sales Market Share by Application (2021-2026) Table 36. Global Needle-Free Injection Device Sales Market Share by Application (2027-2032) Table 37. Global Needle-Free Injection Device Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 38. Global Needle-Free Injection Device Revenue by Application (2021-2026) & (k units) Table 39. Global Needle-Free Injection Device Revenue by Application (2027-2032) & (k units) Table 40. Global Needle-Free Injection Device Revenue Market Share by Application (2021-2026) Table 41. Global Needle-Free Injection Device Revenue Market Share by Application (2027-2032) Table 42. Global Needle-Free Injection Device Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Needle-Free Injection Device Sales by Region (2021-2026) & (k units) Table 44. Global Needle-Free Injection Device Sales Market Share by Region (2021-2026) Table 45. Global Needle-Free Injection Device Sales Forecasted by Region (2027-2032) & (k units) Table 46. Global Needle-Free Injection Device Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Needle-Free Injection Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 48. North America Needle-Free Injection Device Sales by Country (2021-2026) & (k units) Table 49. North America Needle-Free Injection Device Sales by Country (2027-2032) & (k units) Table 50. Europe Needle-Free Injection Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 51. Europe Needle-Free Injection Device Sales by Country (2021-2026) & (k units) Table 52. Europe Needle-Free Injection Device Sales by Country (2027-2032) & (k units) Table 53. Asia Pacific Needle-Free Injection Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Asia Pacific Needle-Free Injection Device Sales by Country (2021-2026) & (k units) Table 55. Asia Pacific Needle-Free Injection Device Sales by Country (2027-2032) & (k units) Table 56. South America, Middle East and Africa Needle-Free Injection Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. South America, Middle East and Africa Needle-Free Injection Device Sales by Country (2021-2026) & (k units) Table 58. South America, Middle East and Africa Needle-Free Injection Device Sales by Country (2027-2032) & (k units) Table 59. Global Needle-Free Injection Device Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Needle-Free Injection Device Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Needle-Free Injection Device Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Needle-Free Injection Device Revenue Market Share by Region (2021-2026) Table 63. Global Needle-Free Injection Device Revenue Market Share by Region (2027-2032) Table 64. Zogenix Company Information Table 65. Zogenix Business Overview Table 66. Zogenix Needle-Free Injection Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Zogenix Needle-Free Injection Device Product Portfolio Table 68. Zogenix Recent Development Table 69. Inovio Company Information Table 70. Inovio Business Overview Table 71. Inovio Needle-Free Injection Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Inovio Needle-Free Injection Device Product Portfolio Table 73. Inovio Recent Development Table 74. Glide Pharma Company Information Table 75. Glide Pharma Business Overview Table 76. Glide Pharma Needle-Free Injection Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Glide Pharma Needle-Free Injection Device Product Portfolio Table 78. Glide Pharma Recent Development Table 79. Akra Dermojet Company Information Table 80. Akra Dermojet Business Overview Table 81. Akra Dermojet Needle-Free Injection Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Akra Dermojet Needle-Free Injection Device Product Portfolio Table 83. Akra Dermojet Recent Development Table 84. Crossject Medical Technology Company Information Table 85. Crossject Medical Technology Business Overview Table 86. Crossject Medical Technology Needle-Free Injection Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Crossject Medical Technology Needle-Free Injection Device Product Portfolio Table 88. Crossject Medical Technology Recent Development Table 89. Injex Pharma Company Information Table 90. Injex Pharma Business Overview Table 91. Injex Pharma Needle-Free Injection Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Injex Pharma Needle-Free Injection Device Product Portfolio Table 93. Injex Pharma Recent Development Table 94. Eternity Healthcare Company Information Table 95. Eternity Healthcare Business Overview Table 96. Eternity Healthcare Needle-Free Injection Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Eternity Healthcare Needle-Free Injection Device Product Portfolio Table 98. Eternity Healthcare Recent Development Table 99. Antares Pharma Company Information Table 100. Antares Pharma Business Overview Table 101. Antares Pharma Needle-Free Injection Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Antares Pharma Needle-Free Injection Device Product Portfolio Table 103. Antares Pharma Recent Development Table 104. Valeritas Company Information Table 105. Valeritas Business Overview Table 106. Valeritas Needle-Free Injection Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Valeritas Needle-Free Injection Device Product Portfolio Table 108. Valeritas Recent Development Table 109. Medical International Technologies Company Information Table 110. Medical International Technologies Business Overview Table 111. Medical International Technologies Needle-Free Injection Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Medical International Technologies Needle-Free Injection Device Product Portfolio Table 113. Medical International Technologies Recent Development Table 114. Penjet Company Information Table 115. Penjet Business Overview Table 116. Penjet Needle-Free Injection Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Penjet Needle-Free Injection Device Product Portfolio Table 118. Penjet Recent Development Table 119. PharmaJet Company Information Table 120. PharmaJet Business Overview Table 121. PharmaJet Needle-Free Injection Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. PharmaJet Needle-Free Injection Device Product Portfolio Table 123. PharmaJet Recent Development Table 124. National Medical Products Company Information Table 125. National Medical Products Business Overview Table 126. National Medical Products Needle-Free Injection Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. National Medical Products Needle-Free Injection Device Product Portfolio Table 128. National Medical Products Recent Development Table 129. Activa Brand Products Company Information Table 130. Activa Brand Products Business Overview Table 131. Activa Brand Products Needle-Free Injection Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Activa Brand Products Needle-Free Injection Device Product Portfolio Table 133. Activa Brand Products Recent Development Table 134. Key Raw Materials Table 135. Raw Materials Key Suppliers Table 136. Needle-Free Injection Device Distributors List Table 137. Needle-Free Injection Device Customers List Table 138. Research Programs/Design for This Report Table 139. Authors List of This Report Table 140. Secondary Sources Table 141. Primary Sources List of Figures Figure 1. Needle-Free Injection Device Product Image Figure 2. Global Needle-Free Injection Device Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Needle-Free Injection Device Market Size (2021-2032) & (US$ Million) Figure 4. Global Needle-Free Injection Device Sales (2021-2032) & (k units) Figure 5. Global Needle-Free Injection Device Average Price (USD/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Needle-Free Injection Device Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Powder Injections Image Figure 9. Liquid Injections Image Figure 10. Depot or Projectile Injection Image Figure 11. Global Needle-Free Injection Device Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Needle-Free Injection Device Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Needle-Free Injection Device Sales Market Share by Type (2021-2032) Figure 14. Global Needle-Free Injection Device Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Needle-Free Injection Device Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Needle-Free Injection Device Revenue Market Share by Type (2021-2032) Figure 17. Drug Injection Image Figure 18. Cosmetic Surgery Use Image Figure 19. Other Image Figure 20. Global Needle-Free Injection Device Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Needle-Free Injection Device Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Needle-Free Injection Device Sales Market Share by Application (2021-2032) Figure 23. Global Needle-Free Injection Device Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Needle-Free Injection Device Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Needle-Free Injection Device Revenue Market Share by Application (2021-2032) Figure 26. North America Needle-Free Injection Device Sales and Growth Rate (2021-2032) & (k units) Figure 27. North America Needle-Free Injection Device Sales Market Share by Country (2021-2032) Figure 28. U.S. Needle-Free Injection Device Sales and Growth Rate (2021-2032) & (k units) Figure 29. Canada Needle-Free Injection Device Sales and Growth Rate (2021-2032) & (k units) Figure 30. Mexico Needle-Free Injection Device Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Needle-Free Injection Device Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Needle-Free Injection Device Sales Market Share by Country (2021-2032) Figure 33. Germany Needle-Free Injection Device Sales and Growth Rate (2021-2032) & (k units) Figure 34. France Needle-Free Injection Device Sales and Growth Rate (2021-2032) & (k units) Figure 35. U.K. Needle-Free Injection Device Sales and Growth Rate (2021-2032) & (k units) Figure 36. Italy Needle-Free Injection Device Sales and Growth Rate (2021-2032) & (k units) Figure 37. Netherlands Needle-Free Injection Device Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Needle-Free Injection Device Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Needle-Free Injection Device Sales Market Share by Country (2021-2032) Figure 40. China Needle-Free Injection Device Sales and Growth Rate (2021-2032) & (k units) Figure 41. Japan Needle-Free Injection Device Sales and Growth Rate (2021-2032) & (k units) Figure 42. South Korea Needle-Free Injection Device Sales and Growth Rate (2021-2032) & (k units) Figure 43. Southeast Asia Needle-Free Injection Device Sales and Growth Rate (2021-2032) & (k units) Figure 44. India Needle-Free Injection Device Sales and Growth Rate (2021-2032) & (k units) Figure 45. Australia Needle-Free Injection Device Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Needle-Free Injection Device Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Needle-Free Injection Device Sales Market Share by Country (2021-2032) Figure 48. Brazil Needle-Free Injection Device Sales and Growth Rate (2021-2032) & (k units) Figure 49. South Africa Needle-Free Injection Device Sales and Growth Rate (2021-2032) & (k units) Figure 50. Saudi Arabia Needle-Free Injection Device Sales and Growth Rate (2021-2032) & (k units) Figure 51. Turkey Needle-Free Injection Device Sales and Growth Rate (2021-2032) & (k units) Figure 52. Argentina Needle-Free Injection Device Sales and Growth Rate (2021-2032) & (k units) Figure 53. UAE Needle-Free Injection Device Sales and Growth Rate (2021-2032) & (k units) Figure 54. Egypt Needle-Free Injection Device Sales and Growth Rate (2021-2032) & (k units) Figure 55. Chile Needle-Free Injection Device Sales and Growth Rate (2021-2032) & (k units) Figure 56. Global Needle-Free Injection Device Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Needle-Free Injection Device Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Needle-Free Injection Device Revenue (2021-2032) & (US$ Million) Figure 59. North America Needle-Free Injection Device Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Needle-Free Injection Device Revenue (2021-2032) & (US$ Million) Figure 61. Europe Needle-Free Injection Device Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Needle-Free Injection Device Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Needle-Free Injection Device Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Needle-Free Injection Device Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Needle-Free Injection Device Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Needle-Free Injection Device Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Needle-Free Injection Device Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Powder Injections
  • Liquid Injections
  • Depot or Projectile Injection
Applications
  • Drug Injection
  • Cosmetic Surgery Use
  • Other
Companies covered
  • Zogenix
  • Inovio
  • Glide Pharma
  • Akra Dermojet
  • Crossject Medical Technology
  • Injex Pharma
  • Eternity Healthcare
  • Antares Pharma
  • Valeritas
  • Medical International Technologies
  • Penjet
  • PharmaJet
  • National Medical Products
  • Activa Brand Products

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Needle-Free Injection Device Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Needle-Free Injection Device Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Needle-Free Injection Device Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Needle-Free Injection Device Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Needle-Free Injection Device Market Dynamics
  1. 2.1 Needle-Free Injection Device Industry Trends
  2. 2.2 Needle-Free Injection Device Industry Drivers
  3. 2.3 Needle-Free Injection Device Industry Opportunities and Challenges
  4. 2.4 Needle-Free Injection Device Industry Restraints
3 Needle-Free Injection Device Market by Manufacturers
  1. 3.1 Global Needle-Free Injection Device Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Needle-Free Injection Device Sales by Manufacturers (2021-2026)
  3. 3.3 Global Needle-Free Injection Device Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Needle-Free Injection Device Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Needle-Free Injection Device Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Needle-Free Injection Device Manufacturers, Product Type & Application
  7. 3.7 Global Needle-Free Injection Device Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Needle-Free Injection Device Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Needle-Free Injection Device Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Needle-Free Injection Device Tier 1, Tier 2, and Tier 3
4 Needle-Free Injection Device Market by Type
  1. 4.1 Needle-Free Injection Device Type Introduction
  2. 4.1.1 Powder Injections
  3. 4.1.2 Liquid Injections
  4. 4.1.3 Depot or Projectile Injection
  5. 4.2 Global Needle-Free Injection Device Sales by Type
  6. 4.2.1 Global Needle-Free Injection Device Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Needle-Free Injection Device Sales by Type (2021-2032)
  8. 4.2.3 Global Needle-Free Injection Device Sales Market Share by Type (2021-2032)
  9. 4.3 Global Needle-Free Injection Device Revenue by Type
  10. 4.3.1 Global Needle-Free Injection Device Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Needle-Free Injection Device Revenue by Type (2021-2032)
  12. 4.3.3 Global Needle-Free Injection Device Revenue Market Share by Type (2021-2032)
5 Needle-Free Injection Device Market by Application
  1. 5.1 Needle-Free Injection Device Application Introduction
  2. 5.1.1 Drug Injection
  3. 5.1.2 Cosmetic Surgery Use
  4. 5.1.3 Other
  5. 5.2 Global Needle-Free Injection Device Sales by Application
  6. 5.2.1 Global Needle-Free Injection Device Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Needle-Free Injection Device Sales by Application (2021-2032)
  8. 5.2.3 Global Needle-Free Injection Device Sales Market Share by Application (2021-2032)
  9. 5.3 Global Needle-Free Injection Device Revenue by Application
  10. 5.3.1 Global Needle-Free Injection Device Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Needle-Free Injection Device Revenue by Application (2021-2032)
  12. 5.3.3 Global Needle-Free Injection Device Revenue Market Share by Application (2021-2032)
6 Global Needle-Free Injection Device Sales by Region
  1. 6.1 Global Needle-Free Injection Device Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Needle-Free Injection Device Sales by Region (2021-2032)
  3. 6.2.1 Global Needle-Free Injection Device Sales by Region (2021-2026)
  4. 6.2.2 Global Needle-Free Injection Device Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Needle-Free Injection Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Needle-Free Injection Device Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Needle-Free Injection Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Needle-Free Injection Device Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Needle-Free Injection Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Needle-Free Injection Device Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Needle-Free Injection Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Needle-Free Injection Device Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Needle-Free Injection Device Revenue by Region
  1. 7.1 Global Needle-Free Injection Device Revenue by Region
  2. 7.1.1 Global Needle-Free Injection Device Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Needle-Free Injection Device Revenue by Region (2021-2026)
  4. 7.1.3 Global Needle-Free Injection Device Revenue by Region (2027-2032)
  5. 7.1.4 Global Needle-Free Injection Device Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Needle-Free Injection Device Revenue (2021-2032)
  8. 7.2.2 North America Needle-Free Injection Device Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Needle-Free Injection Device Revenue (2021-2032)
  11. 7.3.2 Europe Needle-Free Injection Device Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Needle-Free Injection Device Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Needle-Free Injection Device Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Needle-Free Injection Device Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Needle-Free Injection Device Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Zogenix
  2. 8.1.1 Zogenix Company Information
  3. 8.1.2 Zogenix Business Overview
  4. 8.1.3 Zogenix Needle-Free Injection Device Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Zogenix Needle-Free Injection Device Product Portfolio
  6. 8.1.5 Zogenix Recent Developments
  7. 8.2 Inovio
  8. 8.2.1 Inovio Company Information
  9. 8.2.2 Inovio Business Overview
  10. 8.2.3 Inovio Needle-Free Injection Device Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Inovio Needle-Free Injection Device Product Portfolio
  12. 8.2.5 Inovio Recent Developments
  13. 8.3 Glide Pharma
  14. 8.3.1 Glide Pharma Company Information
  15. 8.3.2 Glide Pharma Business Overview
  16. 8.3.3 Glide Pharma Needle-Free Injection Device Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Glide Pharma Needle-Free Injection Device Product Portfolio
  18. 8.3.5 Glide Pharma Recent Developments
  19. 8.4 Akra Dermojet
  20. 8.4.1 Akra Dermojet Company Information
  21. 8.4.2 Akra Dermojet Business Overview
  22. 8.4.3 Akra Dermojet Needle-Free Injection Device Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Akra Dermojet Needle-Free Injection Device Product Portfolio
  24. 8.4.5 Akra Dermojet Recent Developments
  25. 8.5 Crossject Medical Technology
  26. 8.5.1 Crossject Medical Technology Company Information
  27. 8.5.2 Crossject Medical Technology Business Overview
  28. 8.5.3 Crossject Medical Technology Needle-Free Injection Device Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Crossject Medical Technology Needle-Free Injection Device Product Portfolio
  30. 8.5.5 Crossject Medical Technology Recent Developments
  31. 8.6 Injex Pharma
  32. 8.6.1 Injex Pharma Company Information
  33. 8.6.2 Injex Pharma Business Overview
  34. 8.6.3 Injex Pharma Needle-Free Injection Device Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Injex Pharma Needle-Free Injection Device Product Portfolio
  36. 8.6.5 Injex Pharma Recent Developments
  37. 8.7 Eternity Healthcare
  38. 8.7.1 Eternity Healthcare Company Information
  39. 8.7.2 Eternity Healthcare Business Overview
  40. 8.7.3 Eternity Healthcare Needle-Free Injection Device Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Eternity Healthcare Needle-Free Injection Device Product Portfolio
  42. 8.7.5 Eternity Healthcare Recent Developments
  43. 8.8 Antares Pharma
  44. 8.8.1 Antares Pharma Company Information
  45. 8.8.2 Antares Pharma Business Overview
  46. 8.8.3 Antares Pharma Needle-Free Injection Device Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Antares Pharma Needle-Free Injection Device Product Portfolio
  48. 8.8.5 Antares Pharma Recent Developments
  49. 8.9 Valeritas
  50. 8.9.1 Valeritas Company Information
  51. 8.9.2 Valeritas Business Overview
  52. 8.9.3 Valeritas Needle-Free Injection Device Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Valeritas Needle-Free Injection Device Product Portfolio
  54. 8.9.5 Valeritas Recent Developments
  55. 8.10 Medical International Technologies
  56. 8.10.1 Medical International Technologies Company Information
  57. 8.10.2 Medical International Technologies Business Overview
  58. 8.10.3 Medical International Technologies Needle-Free Injection Device Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Medical International Technologies Needle-Free Injection Device Product Portfolio
  60. 8.10.5 Medical International Technologies Recent Developments
  61. 8.11 Penjet
  62. 8.11.1 Penjet Company Information
  63. 8.11.2 Penjet Business Overview
  64. 8.11.3 Penjet Needle-Free Injection Device Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Penjet Needle-Free Injection Device Product Portfolio
  66. 8.11.5 Penjet Recent Developments
  67. 8.12 PharmaJet
  68. 8.12.1 PharmaJet Company Information
  69. 8.12.2 PharmaJet Business Overview
  70. 8.12.3 PharmaJet Needle-Free Injection Device Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 PharmaJet Needle-Free Injection Device Product Portfolio
  72. 8.12.5 PharmaJet Recent Developments
  73. 8.13 National Medical Products
  74. 8.13.1 National Medical Products Company Information
  75. 8.13.2 National Medical Products Business Overview
  76. 8.13.3 National Medical Products Needle-Free Injection Device Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 National Medical Products Needle-Free Injection Device Product Portfolio
  78. 8.13.5 National Medical Products Recent Developments
  79. 8.14 Activa Brand Products
  80. 8.14.1 Activa Brand Products Company Information
  81. 8.14.2 Activa Brand Products Business Overview
  82. 8.14.3 Activa Brand Products Needle-Free Injection Device Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Activa Brand Products Needle-Free Injection Device Product Portfolio
  84. 8.14.5 Activa Brand Products Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Needle-Free Injection Device Value Chain Analysis
  2. 9.1.1 Needle-Free Injection Device Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Needle-Free Injection Device Production Mode & Process
  6. 9.2 Needle-Free Injection Device Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Needle-Free Injection Device Distributors
  9. 9.2.3 Needle-Free Injection Device Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst